Continuous Midazolam Infusion in the Treatment of Uncontrollable Neonatal Seizures

Kun Chieh Hu, Nan Chang Chiu, Che Sheng Ho, Sung Tse Lee, Ein Yiao Shen

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

A prospective open-label study was designed to determine the efficacy and safety of continuous midazolam infusion in neonates with uncontrollable neonatal seizures. Patients whose seizures could not be controlled by diazepam, phenytoin or phenobarbital were enrolled. Midazolam was given as an intravenous bolus dose followed by continuous intravenous infusion. Thirty-two patients fulfilled the inclusion criteria. Midazolam terminated the seizures in all patients. The maximum dose of midazolam ranged from 1 μg/kg/min to 15 μg/kg/min, with average of 4 μg/kg/min. Four patients had recurrent seizures, which stop after midazolam was reinstituted. There were no significant changes in serum sodium, potassium, calcium or glucose in any of the patients. Adverse effects included hypotension in 12 patients (38%) that was successfully controlled with inotropic agents (dopamine and/or dobutamine) and transient urinary retention in 12 (38%). Our study suggests that midazolam is safe and effective for the treatment of uncontrollable neonatal seizures.

Original languageEnglish
Pages (from-to)279-281
Number of pages3
JournalActa Paediatrica Taiwanica
Volume44
Issue number5
Publication statusPublished - Sep 2003

Fingerprint

Midazolam
Seizures
Therapeutics
Dopamine Agents
Dobutamine
Urinary Retention
Phenytoin
Phenobarbital
Diazepam
Intravenous Infusions
Hypotension
Potassium
Sodium
Newborn Infant
Calcium
Safety
Glucose
Serum

Keywords

  • Midazolam
  • Neonatal seizures
  • Uncontrollable seizures

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Hu, K. C., Chiu, N. C., Ho, C. S., Lee, S. T., & Shen, E. Y. (2003). Continuous Midazolam Infusion in the Treatment of Uncontrollable Neonatal Seizures. Acta Paediatrica Taiwanica, 44(5), 279-281.

Continuous Midazolam Infusion in the Treatment of Uncontrollable Neonatal Seizures. / Hu, Kun Chieh; Chiu, Nan Chang; Ho, Che Sheng; Lee, Sung Tse; Shen, Ein Yiao.

In: Acta Paediatrica Taiwanica, Vol. 44, No. 5, 09.2003, p. 279-281.

Research output: Contribution to journalArticle

Hu, KC, Chiu, NC, Ho, CS, Lee, ST & Shen, EY 2003, 'Continuous Midazolam Infusion in the Treatment of Uncontrollable Neonatal Seizures', Acta Paediatrica Taiwanica, vol. 44, no. 5, pp. 279-281.
Hu, Kun Chieh ; Chiu, Nan Chang ; Ho, Che Sheng ; Lee, Sung Tse ; Shen, Ein Yiao. / Continuous Midazolam Infusion in the Treatment of Uncontrollable Neonatal Seizures. In: Acta Paediatrica Taiwanica. 2003 ; Vol. 44, No. 5. pp. 279-281.
@article{8de369cc45504c789290d9f35ee5f613,
title = "Continuous Midazolam Infusion in the Treatment of Uncontrollable Neonatal Seizures",
abstract = "A prospective open-label study was designed to determine the efficacy and safety of continuous midazolam infusion in neonates with uncontrollable neonatal seizures. Patients whose seizures could not be controlled by diazepam, phenytoin or phenobarbital were enrolled. Midazolam was given as an intravenous bolus dose followed by continuous intravenous infusion. Thirty-two patients fulfilled the inclusion criteria. Midazolam terminated the seizures in all patients. The maximum dose of midazolam ranged from 1 μg/kg/min to 15 μg/kg/min, with average of 4 μg/kg/min. Four patients had recurrent seizures, which stop after midazolam was reinstituted. There were no significant changes in serum sodium, potassium, calcium or glucose in any of the patients. Adverse effects included hypotension in 12 patients (38{\%}) that was successfully controlled with inotropic agents (dopamine and/or dobutamine) and transient urinary retention in 12 (38{\%}). Our study suggests that midazolam is safe and effective for the treatment of uncontrollable neonatal seizures.",
keywords = "Midazolam, Neonatal seizures, Uncontrollable seizures",
author = "Hu, {Kun Chieh} and Chiu, {Nan Chang} and Ho, {Che Sheng} and Lee, {Sung Tse} and Shen, {Ein Yiao}",
year = "2003",
month = "9",
language = "English",
volume = "44",
pages = "279--281",
journal = "Pediatrics and Neonatology",
issn = "1875-9572",
publisher = "臺灣兒科醫學會",
number = "5",

}

TY - JOUR

T1 - Continuous Midazolam Infusion in the Treatment of Uncontrollable Neonatal Seizures

AU - Hu, Kun Chieh

AU - Chiu, Nan Chang

AU - Ho, Che Sheng

AU - Lee, Sung Tse

AU - Shen, Ein Yiao

PY - 2003/9

Y1 - 2003/9

N2 - A prospective open-label study was designed to determine the efficacy and safety of continuous midazolam infusion in neonates with uncontrollable neonatal seizures. Patients whose seizures could not be controlled by diazepam, phenytoin or phenobarbital were enrolled. Midazolam was given as an intravenous bolus dose followed by continuous intravenous infusion. Thirty-two patients fulfilled the inclusion criteria. Midazolam terminated the seizures in all patients. The maximum dose of midazolam ranged from 1 μg/kg/min to 15 μg/kg/min, with average of 4 μg/kg/min. Four patients had recurrent seizures, which stop after midazolam was reinstituted. There were no significant changes in serum sodium, potassium, calcium or glucose in any of the patients. Adverse effects included hypotension in 12 patients (38%) that was successfully controlled with inotropic agents (dopamine and/or dobutamine) and transient urinary retention in 12 (38%). Our study suggests that midazolam is safe and effective for the treatment of uncontrollable neonatal seizures.

AB - A prospective open-label study was designed to determine the efficacy and safety of continuous midazolam infusion in neonates with uncontrollable neonatal seizures. Patients whose seizures could not be controlled by diazepam, phenytoin or phenobarbital were enrolled. Midazolam was given as an intravenous bolus dose followed by continuous intravenous infusion. Thirty-two patients fulfilled the inclusion criteria. Midazolam terminated the seizures in all patients. The maximum dose of midazolam ranged from 1 μg/kg/min to 15 μg/kg/min, with average of 4 μg/kg/min. Four patients had recurrent seizures, which stop after midazolam was reinstituted. There were no significant changes in serum sodium, potassium, calcium or glucose in any of the patients. Adverse effects included hypotension in 12 patients (38%) that was successfully controlled with inotropic agents (dopamine and/or dobutamine) and transient urinary retention in 12 (38%). Our study suggests that midazolam is safe and effective for the treatment of uncontrollable neonatal seizures.

KW - Midazolam

KW - Neonatal seizures

KW - Uncontrollable seizures

UR - http://www.scopus.com/inward/record.url?scp=0345828863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345828863&partnerID=8YFLogxK

M3 - Article

C2 - 14964983

AN - SCOPUS:0345828863

VL - 44

SP - 279

EP - 281

JO - Pediatrics and Neonatology

JF - Pediatrics and Neonatology

SN - 1875-9572

IS - 5

ER -